Cigna Corporation
CI
Rank in Stocks
#302
Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut,... Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments. Its Evernorth division offers a comprehensive array of coordinated and specialized health solutions, including pharmacy services, benefits administration, care management and delivery, and advanced intelligence solutions. These offerings cater to a diverse clientele, such as health plans, employers, government entities, and healthcare providers. Meanwhile, the Cigna Healthcare segment delivers an extensive portfolio of products and services, encompassing medical, pharmaceutical, behavioral health, dental, vision, and health advocacy programs for both insured and self-insured customers. This segment also provides Medicare Advantage, Medicare Supplement, and Medicare Part D plans specifically for seniors, in addition to individual health insurance options available on and off public exchanges. Globally, Cigna Healthcare extends international health coverage and benefits to mobile professionals and employees of multinational organizations. Furthermore, the company issues permanent insurance contracts to corporations, designed to cover the lives of specific employees for funding future benefit obligations. Cigna distributes its various offerings through insurance brokers and consultants, direct sales channels to employers, unions, and individuals, and via both private and public exchanges.
Share Price
$302.38
Last synced: 2026-10-16
Market Cap
$79.90B
Change (1 day)
1.25%
Change (1 year)
1.04%
Country
US
Trade Cigna Corporation (CI)
Category
Healthcare
P/E ratio for Cigna Corporation (CI)
P/E ratio as of October 2026 TTM: 11.94
According to Cigna Corporation latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 11.94. At the end of 2024 the company had a P/E ratio of 22.54.
P/E ratio history for Cigna Corporation from 2000 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 11.94 | -2.84% |
| 2025 | 12.29 | -45.48% |
| 2024 | 22.54 | 30.92% |
| 2023 | 17.22 | 11.26% |
| 2022 | 15.47 | 7.07% |
| 2021 | 14.45 | 60.87% |
| 2020 | 8.98 | -40.35% |
| 2019 | 15.06 | -15.22% |
| 2018 | 17.76 | -19.59% |
| 2017 | 22.09 | 21.08% |
| 2016 | 18.24 | 1.93% |
| 2015 | 17.90 | 38.55% |
| 2014 | 12.92 | -21.95% |
| 2013 | 16.55 | 76.44% |
| 2012 | 9.38 | 3.98% |
| 2011 | 9.02 | 15.37% |
| 2010 | 7.82 | 5.35% |
| 2009 | 7.42 | -53.61% |
| 2008 | 16.00 | 17.27% |
| 2007 | 13.65 | 8.59% |
| 2006 | 12.57 | 43.58% |
| 2005 | 8.75 | 13.10% |
| 2004 | 7.74 | -39.17% |
| 2003 | 12.72 | -198.06% |
| 2002 | -12.97 | -187.25% |
| 2001 | 14.87 | -31.90% |
| 2000 | 21.84 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 22.58 | 89.09% |
US
|
|
| 23.60 | 97.64% |
US
|
|
| 19.03 | 59.33% |
US
|
|
| 40.15 | 236.22% |
US
|
|
| - | - |
US
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.